|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Zeng H, Zhang S and He J:
Annual report on status of cancer in China, 2011. Chin J Cancer
Res. 27:2–12. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Moretti D, Del Bello B, Allavena G and
Maellaro E: Calpains and cancer: Friends or enemies? Arch Biochem
Biophys. 564:26–36. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Carragher NO and Frame MC: Calpain: A role
in cell transformation and migration. Int J Biochem Cell Biol.
34:1539–1543. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sorimachi H, Hata S and Ono Y: Impact of
genetic insights into calpain biology. J Biochem. 150:23–37. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang Y and Wang KK: The calpain family
and human disease. Trends Mol Med. 7:355–362. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Storr SJ, Carragher NO, Frame MC, Parr T
and Martin SG: The calpain system and cancer. Nat Rev Cancer.
11:364–374. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang Z, Hoffmann FW, Norton RL, Hashimoto
AC and Hoffmann PR: Selenoprotein K is a novel target of m-calpain,
and cleavage is regulated by Toll-like receptor-induced calpastatin
in macrophages. J Biol Chem. 286:34830–34838. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li X, Li Y, Shan L, Shen E, Chen R and
Peng T: Over-expression of calpastatin inhibits calpain activation
and attenuates myocardial dysfunction during endotoxaemia.
Cardiovasc Res. 83:72–79. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Marshall CB, Nishikawa T, Osawa M,
Stathopulos PB and Ikura M: Calmodulin and STIM proteins: Two major
calcium sensors in the cytoplasm and endoplasmic reticulum. Biochem
Biophys Res Commun. 460:5–21. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Barnes JA and Gomes AV: PEST sequences in
calmodulin-binding proteins. Mol Cell Biochem. 149–150:17–27. 1995.
View Article : Google Scholar
|
|
12
|
Sivanandam A, Murthy S, Chinnakannu K, Bai
VU, Kim SH, Barrack ER, Menon M and Reddy GP: Calmodulin protects
androgen receptor from calpain-mediated breakdown in prostate
cancer cells. J Cell Physiol. 226:1889–1896. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Molinari M, Anagli J and Carafoli E: PEST
sequences do not influence substrate susceptibility to calpain
proteolysis. J Biol Chem. 270:2032–2035. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang KK, Villalobo A and Roufogalis BD:
Calmodulin-binding proteins as calpain substrates. Biochem J.
262:693–706. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang H, Murthy S, Sarkar FH, Sheng S,
Reddy GP and Dou QP: Calpain-mediated androgen receptor breakdown
in apoptotic prostate cancer cells. J Cell Physiol. 217:569–576.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu T, Mendes DE and Berkman CE: Prolonged
androgen deprivation leads to overexpression of calpain 2:
Implications for prostate cancer progression. Int J Oncol.
44:467–472. 2014.PubMed/NCBI
|
|
17
|
Lakshmikuttyamma A, Selvakumar P, Kanthan
R, Kanthan SC and Sharma RK: Overexpression of m-calpain in human
colorectal adenocarcinomas. Cancer Epidemiol Biomarkers Prev.
13:1604–1609. 2004.PubMed/NCBI
|
|
18
|
Storr SJ, Lee KW, Woolston CM, Safuan S,
Green AR, Macmillan RD, Benhasouna A, Parr T, Ellis IO and Martin
SG: Calpain system protein expression in basal-like and
triple-negative invasive breast cancer. Ann Oncol. 23:2289–2296.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Storr SJ, Safuan S, Woolston CM,
Abdel-Fatah T, Deen S, Chan SY and Martin SG: Calpain-2 expression
is associated with response to platinum based chemotherapy,
progression-free and overall survival in ovarian cancer. J Cell Mol
Med. 16:2422–2428. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ivanova EV, Kondakova IV, Spirina LV,
Afanas'ev SG, Avgustinovich AV and Cheremisina OV:
Chymotrypsin-like activity of proteasomes and total calpain
activity in gastric and colorectal cancer. Bull Exp Biol Med.
157:781–784. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Storr SJ, Pu X, Davis J, Lobo D,
Reece-Smith AM, Parsons SL, Madhusudan S and Martin SG: Expression
of the calpain system is associated with poor clinical outcome in
gastro-oesophageal adenocarcinomas. J Gastroenterol. 48:1213–1221.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rios-Doria J, Day KC, Kuefer R, Rashid MG,
Chinnaiyan AM, Rubin MA and Day ML: The role of calpain in the
proteolytic cleavage of E-cadherin in prostate and mammary
epithelial cells. J Biol Chem. 278:1372–1379. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Panis C, Pizzatti L, Corrêa S, Binato R,
Lemos GF, Herrera AC, Seixas TF, Cecchini R and Abdelhay E: The
positive is inside the negative: HER2-negative tumors can express
the HER2 intracellular domain and present a HER2-positive
phenotype. Cancer Lett. 357:186–195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ye Y, Tian H, Lange AR, Yearsley K,
Robertson FM and Barsky SH: The genesis and unique properties of
the lymphovascular tumor embolus are because of calpain-regulated
proteolysis of E-cadherin. Oncogene. 32:1702–1713. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Libertini SJ, Tepper CG, Rodriguez V,
Asmuth DM, Kung HJ and Mudryj M: Evidence for calpain-mediated
androgen receptor cleavage as a mechanism for androgen
independence. Cancer Res. 67:9001–9005. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Storr SJ, Woolston CM, Barros FF, Green
AR, Shehata M, Chan SY, Ellis IO and Martin SG: Calpain-1
expression is associated with relapse-free survival in breast
cancer patients treated with trastuzumab following adjuvant
chemotherapy. Int J Cancer. 129:1773–1780. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Croce K, Flaumenhaft R, Rivers M, Furie B,
Furie BC, Herman IM and Potter DA: Inhibition of calpain blocks
platelet secretion, aggregation, and spreading. J Biol Chem.
274:36321–36327. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Menon S, Kang CM and Beningo KA:
Galectin-3 secretion and tyrosine phosphorylation is dependent on
the calpain small subunit, Calpain 4. Biochem Biophys Res Commun.
410:91–96. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Peltier J, Bellocq A, Perez J, Doublier S,
Dubois YC, Haymann JP, Camussi G and Baud L: Calpain activation and
secretion promote glomerular injury in experimental
glomerulonephritis: Evidence from calpastatin-transgenic mice. J Am
Soc Nephrol. 17:3415–3423. 2006. View Article : Google Scholar : PubMed/NCBI
|
